Objective: To evaluate the effect of robot-mediated therapy on arm dysfunction post stroke. Design: A series of single-case studies using a randomized multiple baseline design with ABC or ACB order. Subjects (n ¼ 20) had a baseline length of 8, 9 or 10 data points. They continued measurement during the B -robot-mediated therapy and C -sling suspension phases. Setting: Physiotherapy department, teaching hospital. Subjects: Twenty subjects with varying degrees of motor and sensory deficit completed the study. Subjects attended three times a week, with each phase lasting three weeks. Interventions: In the robot-mediated therapy phase they practised three functional exercises with haptic and visual feedback from the system. In the sling suspension phase they practised three single-plane exercises. Each treatment phase was three weeks long. Main measures: The range of active shoulder flexion, the Fugl-Meyer motor assessment and the Motor Assessment Scale were measured at each visit. Results: Each subject had a varied response to the measurement and intervention phases. The rate of recovery was greater during the robot-mediated therapy phase than in the baseline phase for the majority of subjects. The rate of recovery during the robot-mediated therapy phase was also greater than that during the sling suspension phase for most subjects. Conclusion: The positive treatment effect for both groups suggests that robot-mediated therapy can have a treatment effect greater than the same duration of non-functional exercises. Further studies investigating the optimal duration of treatment in the form of a randomized controlled trial are warranted.
Introduction
In stroke, residual deficits in the function of the hand and arm are common; this functional difficulty is recognized as contributing to poor quality of life and decreased well-being. 1 It is also recognized that for optimal cortical re-organization to occur post stroke, there is a requirement for high levels of repetition of tasks and exercises that are both challenging and engaging. [2] [3] [4] Nonetheless, it has been suggested that the dose of physiotherapy intervention that occurs post stroke is, at best, 'homeopathic' 5 and that the arm receives significantly less attention than the lower limb. 6 There is some evidence to suggest that if the duration or intensity of intervention for the arm is increased sufficiently, it will lead to an improved outcome of motor impairment in the affected arm. 7, 8 Attention is now focusing on novel technologies that can enable individuals to complete repetitious exercise programmes to supplement the traditional 'handson', labour-intensive physiotherapy. One way of delivering more intervention without the need for more therapists is by using robotic technology. The results of four robotic systems have been published in the clinical literature to date. In the United States the MIME, [9] [10] [11] [12] [13] MIT-Manus [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] and the ARM-Guide [25] [26] [27] systems have demonstrated results that suggest the delivery of exercise intervention using robotic devices can have positive effects on range of motion, strength and motor activity. Functional improvement has been 'inconsistently reported' and minimal. 20, 28, 29 In Europe, three systems have been developed for arm exercises post stroke -the Reharob, 30 Bi-Manu-Track 31 and GENTLE/s 32 systems. With respect to the latter system, the results of a singlecase study suggesting a positive treatment effect have been published. 33 The aim of this paper is to present results from the cohort of 20 subjects.
Methods

Design
A series of single-case studies, using randomized multiple baseline design, with randomized treatment phases (ABC or ACB) was applied. Subjects were randomly allocated by choosing a sealed envelope from two selections containing the possible length of baseline and the possible treatment orders. In the 'A' or baseline phase, all subjects were measured three times per week, yielding 8, 9 or 10 data points. During the 'B' or robot-mediated therapy phase, measurement continued three times per week and in addition the subjects received the robot-mediated therapy treatment. The 'C' or sling suspension phase was employed as a control phase, to observe the effect of a similar dosage of intervention, which also involved repetitious movement, with ongoing trice weekly measurement.
Participants
Twenty subjects were included in the study. All had residual arm dysfunction following a first episode of stroke. To be included they had to be able to provide informed consent and have sufficient communication abilities to complete the outcome measures and treatment procedures (this was assessed by their speech and language therapist). They were excluded if they had a pacemaker (due to possible electromagnetic field interference of the system). A sample of convenience was employed and senior physiotherapists working in stroke rehabilitation in three academic teaching hospitals in Dublin knowledgeable of the inclusion criteria and trial methodology suggested names of potential participants who had attended their physiotherapy service. They were then assessed for their suitability (Short Orientation Memory Concentration Test 34 score greater than 20, residual arm deficit), presented with an information leaflet and following informed consent were recruited to the study. The study protocol was approved by the local ethics committee.
Intervention
The robot-mediated therapy system comprises a three-degree of freedom haptic interface arm (Haptic Master, Fokker Control Systems) with a wrist attachment mechanism, two embedded computers, a monitor and speakers, seating for the subject and an overhead arm support system. Treatment with the robot-mediated therapy system involved the subject being seated at the workstation. The affected arm was de-weighted through a free moving elbow splint attached to the overhead frame; this was to remove the effect of gravity and minimize any subluxation present. Support for the trunk was provided by a seat harness/jacket which also provided a physical prompt when compensatory trunk movements were used. The subject was connected to the system by a wrist splint that held their wrist in 15 extension, which was in turn connected to a magnetic safety connection that prevented excessive force being applied to the arm.
During the robot-mediated therapy phase, subjects had 30 minutes of intervention three times per week. The intervention involved the practice of three exercises appropriate to their needs, for 10 minutes each, and included exercises such as hand-to-mouth movements, reaching at table height and a reaching exercise to shoulder height. Feedback on the direction of the movement required and completion of the exercises was provided on-screen through a series of target balls. In addition to visual feedback, haptic feedback was provided and was perceived by the subject as a feeling of increased resistance to movement when their hand strayed from the programmed movement pattern. The amount of assistance required by the subject is also programmed so that passive, active assisted or active movements can be completed.
The sling suspension phase involved the subject lying on their good side with their affected arm supported in an arm and forearm sling. Similar to the robot-mediated therapy they performed three exercises for 10 minutes each: elbow flexion/extension with shoulder in neutral, shoulder flexion with elbow flexion and shoulder flexion with elbow extension. The minimum amount of assistance required to complete the movement was provided by the therapist and verbal cues were standardized.
Outcome measurement
Measures were taken in the same order at the start of every visit, which was at the same time every visit for each subject. The active range of motion of shoulder flexion was measured using the standardized positions as described by Norkin and White. 35 The Fugl-Meyer 36 Assessment of Motor Recovery after Stroke was used to measure the impairment of the function of the arm and the Motor Assessment Scale 37 measured limitations of arm activity. Since several background characteristics have been demonstrated to have an effect on the outcome of arm recovery, they were also measured. Sensation was measured using the Nottingham sensory assessment, 38 hemi-neglect using the Star Cancellation Test, 39 pain on visual analogue scale for those with no hemi-neglect and a verbal scale for those with abnormal Star Cancellation Test score. The modified Ashworth Scale 40 was used to measure elbow tone at the start of the study and at the end of each phase.
The investigator carried out both assessments and treatment. To decrease possible bias the scoring sheets were not totalled on the day of testing and were filed until the end of the study when they were then totalled and entered into an Excel file.
Data analysis
Initially, the data from this trial were analysed visually, however due to the high variability between measures and difficulties in comparing the response of one participant to another a statistical method of analysis was sought. Several authors have suggested drawing lines through the data to assist visual analysis, 41, 42 and using linear regression to statistically evaluate single-case studies 43, 44 hence the general linear model was chosen to estimate a least squares line through each phase and the slope was considered as a measure of the rate of recovery. The model used allowed for an interaction effect between each participant and each time variable. In addition, it accounted for the fact that each participant started at a different baseline value and had a different rate of recovery for each phase.
A comparison of the fitted model to the raw data was completed; the continuity of the lines and the similarity of raw and predicted data demonstrated the appropriateness of the model and suggested that the slope values accurately represent the rate of recovery between phases. Examination of the residual plots for all variables was also satisfactory suggesting that the statistical model was a good fit of the data.
To analyse the change in modified Ashworth Scale score, the Wilcoxon signed rank test was used.
Results
The characteristics of the 10 subjects in each group are included in Tables 1 and 2 . None of the participants reported any adverse effects from the treatment, except for subject 3 who reported an increase in shoulder pain following robotmediated therapy, however her pain score at the end of the study was still less than that at baseline. It was hypothesized that this was due to the fact that she had a decrease in passive range of motion of external rotation and was working at the end of this range during treatment. Subject 2 missed three appointments during the sling suspension phase, subject 13 missed one appointment during the sling suspension phase, and subject 18 missed one treatment in each of the sling suspension and robot-mediated therapy phases. All other participants completed all treatments and measurements. Some participants had ongoing physiotherapy once or twice a week, however none of them had a change in intervention or duration of home exercise programme (HEP) from baseline to robot-mediated therapy and sling suspension phases.
The results of the slope values for the arm section of the Fugl-Meyer (FM-ARM) scale are presented in Table 3 . Seven subjects had slope values in the robot-mediated therapy phase that were higher than those in both the baseline and sling suspension phases. The maximum slope value in the robot-mediated therapy phase, seen in subject 1, suggests an increase of 10.62 points in the arm section of the Fugl-Meyer over the nine robot-mediated therapy treatments. The mean difference between the baseline and robot-mediated therapy phases for group 1 was À0.25 (confidence interval (CI) À0.52, 0.020, P ¼ 0.066), suggesting a trend for a significantly higher slope in the robot-mediated therapy phase. The mean difference between baseline and robot-mediated therapy phases for group 2 was À0.056 (CI À0.406, 0.294, P ¼ 0.726). The mean difference between robotmediated therapy and sling suspension phases for group 1 was 0.197 (CI À0.055, 0.449, P ¼ 0.111). The mean difference between sling suspension and robot-mediated therapy phases for group 2 was À0.048 (CI À0.25, 0.154, P ¼ 0.604).
The results of the slope values for the total of the three arm sections of the Motor Assessment Scale are presented in Table 4 . Eight subjects had slope values in the robot-mediated therapy phase that were higher than both the baseline and sling suspension phases. The maximum slope value in the robot-mediated therapy phase, seen in subject 5, suggests an increase of 4.41 points in the 
arm sections of the Motor Assessment Scale over the nine robot-mediated therapy treatments. The mean difference between the slopes of the baseline and robot-mediated therapy phases for group 1 was À0.114 (CI À0.307, 0.079, P ¼ 0.215). The mean difference between slopes of the baseline and robot-mediated therapy phases for group 2 was À0.022 (CI À0.158, 0.1142, P ¼ 0.723). The mean difference between slopes of the robot-mediated therapy and sling suspension phases for group 1 was 0.039 (CI À0.111, 0.189, P ¼ 0.571). The mean difference between slopes of the sling suspension and robot-mediated therapy phases for group 2 was À0.143 (CI À0.2535, À0.0325, P ¼ 0.017), suggesting a significantly higher mean slope in the robot-mediated therapy phase.
The results of the slope values for the active range of motion of shoulder flexion are presented in Table 5 . Twelve subjects had slope values in the robot-mediated therapy phase that were higher than both the baseline and sling suspension phases. The maximum slope value in the robotmediated therapy phase, seen in subject 5, suggests an increase of 6.93 degrees over the nine robotmediated therapy treatments. Values in bold are where robot-mediated therapy slope is greater than both sling suspension and baseline. RMT, robot-mediated therapy; SS, sling suspension. Values in bold are where robot-mediated therapy slope is greater than both sling suspension and baseline. RMT, robot-mediated therapy; SS, sling suspension.
The mean difference between the baseline and robot-mediated therapy phases for group 1 was À0.094 (CI À0.38, 0.192, P ¼ 0.477). The mean difference between the slopes of the baseline and robot-mediated therapy phases for group 2 was À0.273 (CI À0.597, 0.051, P ¼ 0.089). The mean difference between slopes of the robot-mediated therapy and sling suspension phases for group 1 was 0.179 (CI À0.020, 0.378, P ¼ 0.072), suggesting a trend for a statistically higher slope in the robot-mediated therapy phase. The mean difference between slopes of the sling suspension and robot-mediated therapy phases for group 2 was À0.188 (CI À0.4068, À0.0308, P ¼ 0.084), suggesting a trend for a statistically higher mean slope in the robot-mediated therapy phase.
The change in score of the modified Ashworth Scale for the elbow in each phase is illustrated in Table 6 . The decrease in scores over the robotmediated therapy phase is significant for group 1 and nearing significance for group 2.
Discussion
In order to evaluate whether the GENTLE/s system had a positive treatment effect, the rates of recovery between the baseline and robotmediated therapy phases were compared. The average value for the slope was higher in the robot-mediated therapy than the baseline phase Values in bold are where robot-mediated therapy slope is greater than both sling suspension and baseline. RMT, robot-mediated therapy; SS, sling suspension. for all three outcome measures for both groups and for several subjects the slope of the sling suspension phase was also greater than that in the baseline. Whilst not significant, the trends emerging from the results of this series of singlecase studies supports the literature that suggests that additional exercise-based intervention involving repetition can produce positive treatment effects. This is consistent with the findings of meta-analyses, 45, 46 which suggest that higher intensities of rehabilitation result in improvements in activities of daily living. This result also concurs with the results of a systematic review of exercise therapy, 47 which also suggests that more intensive exercise therapy may be beneficial in improving outcome of the arm.
In seven subjects (1, 3, 4, 5, 6, 7 and 9) the slope value was greater during the robot-mediated therapy phase than both the baseline and sling suspension phases for all three outcome measures. All of these subjects shared the absence of hemianopia and a score greater than 20 on the Fugl-Meyer Scale. Subjects 10, 11, 12 and 19, who had no active motion of shoulder flexion on entry to the study, did not demonstrate any clinically significant benefit from either sling suspension or robot-mediated therapy. This supports the findings of studies that suggest that additional intervention is most beneficial for those with some movement initially. 48 Further research should consider whether adding robot-mediated therapy early post stroke can improve outcome for those with little or no movement initially.
All three of the outcome variables for subject 17, and several other measures for other subjects, had the highest slope value during the baseline phase. As it is unlikely, given the time post stroke, that recovery was greater during these three weeks, it is possible that the rate of increase in scores could be due to a learning effect of the outcome measure, or due to some degree of unmasking of learned non-use in the affected arm.
Contrary to the belief that resisted exercise has a negative effect on tone, the GENTLE/s system had, for the majority of subjects, a positive effect on the tone of the affected elbow. Group 1 had a statistically significant decrease in tone over the robot-mediated therapy phase, while the scores for the majority of subjects in group 2 did not increase over the robot-mediated therapy phase.
Probably the most striking finding of this study was that no two subjects had the same response to the intervention. Both the magnitude of the differences in slopes and the outcome variables affected differed between individuals. This highlights the need for studies evaluating treatments for subjects with stroke to provide information about the subjects who have particularly good or bad responses to the intervention. It is this detail of information that is needed by clinicians when making decisions as to how best to treat that particular patient.
The comparison of the robot-mediated therapy and sling suspension phases allows the specific components of the intervention responsible for the treatment effect to be evaluated. The treatments differ principally in the fact that sling suspension involves single-plane, nonfunctional movements with no visual feedback, whereas robot-mediated therapy involves the repeated practice of functional, meaningful, challenging movements with haptic and visual feedback. There were higher rates of recovery during the robot-mediated therapy than the sling suspension phase on average for both groups for the active range of motion measure, and for subjects 1, 2, 3, 4, 5, 6, 7 and 9 for all three measures, suggesting that adding visual feedback through virtual reality and the assistance of the robot can improve outcome. This concurs with the results of Plautz et al. 9 who found that cortical reorganization in monkeys was optimized when the skill practised was challenging and engaging. It is also supported by work by Wu et al. 49 who found that the kinematics of reaching with the affected arm improved when a meaningful object was present as opposed to reaching into space. It is also possible that the completion of virtual reality tasks, as opposed to single planar movements, increased attention, a factor that is important for motor learning post stroke. 50 The common characteristics of these seven patients who appeared to have a better response to robot-mediated therapy than sling suspension is that they all had no hemianopia, a Star Cancellation Test score greater than 50 and a Fugl-Meyer score of greater than 20 on admission to the study. They had varying levels of pain, sensation and tone and were at varying times post stroke; hand dominance was also not a factor.
The lack of statistical significance and variable results may be further explained by the variability of the data. Significant variability during the measurement only phase was found in all measures, especially in goniometry. The tester was an experienced senior clinician who was familiar with the outcome measures having used them both clinically and in a pilot study prior to this study and the reliability coefficients published for the measures suggested good test-retest reliability. However on plotting the data the variability was great and prohibited visual analysis. Further published data on reliability is required and for future studies the test-retest variability should be considered when choosing both the outcome measure and the criteria for clinically and statistically significant change.
Also, while the absolute values for the rate of recovery seem positive, the actual change in score on the outcome measures may not be clinically meaningful to either subjects or therapists. This may be because the actual dosage of the intervention, 4.5 hours over three weeks, is only a very small proportion of the subject's waking hours. Other studies 6, 51, 52 have delivered additional interventions of 900-1200 minutes and have reported a limited impact on impairment and function. It would appear from this literature that for additional intervention to have an impact, because of the nature of the arm deficit, the compliance of the participants and exercise delivered for in excess of 1200 minutes is required. Compliance was not an issue in this study and while the duration of GENTLE/s intervention represents the duration of treatment at most outpatient physiotherapy departments in Ireland, it would be interesting to evaluate the effect of the GENTLE/s system on arm function with a greater intensity and during the first three months post stroke when recovery is at its maximum. Increasing the intensity of the intervention may produce a change in activity limitations that is sufficient to influence participation.
Conclusion
The trends emerging from the results of this series of single-case studies support the literature that suggests that additional exercise-based intervention involving repetition produces positive treatment effects. Treatment using the GENTLE/s robot-mediated therapy system may be preferable to one that simply involves repetitious exercises but further studies comparing it to additional conventional therapy are required. The differing response of the 20 subjects highlights the knowledge that subjects with stroke are inherently heterogeneous and that describing study subjects in terms of age and time post stroke is not sufficient. Multicentre randomized controlled trials with large numbers of well-described subjects and treatment and control groups with similar predictive factors for recovery are required to inform clinical practice and to increase the evidence base for robot-mediated therapy. The optimal duration of intervention with robotmediated therapy is probably greater than that delivered in this study and research to investigate both the optimal dose and timing of intervention is required. While robot-mediated therapy has been developed in response to the output of both the clinical and neurophysiological literature, studies that combine treatment effects with mapping of change at brain level will most likely further knowledge of the mechanisms of recovery and guide physiotherapists in modifying treatments that optimally use this information.
Ultimately the goal of rehabilitation is to optimize recovery of the post stroke to enable the patient to return to their place in society and prevent decreased well-being and quality of life. It is clear that an increase the amount of intervention that the arm receives is required and robotic technology is ideally placed to deliver additional exercise-based intervention. The principles of robot-mediated therapy are based on the output of the physiotherapy and neurophysiological research and the results of this study, and those of researchers in the USA and Europe, provide an increasing evidence base for this novel intervention. 402 S Coote et al.
